Article
Effect of Genetic Polymorphism of the CYP2D6 Gene on the Efficacy and Safety of Fluvoxamine in Major Depressive Disorder.
American journal of therapeutics - 3 Jun 2021
Zastrozhin Michael, Skryabin Valentin, Smirnov Valeriy, Zastrozhina Anastasiya, Grishina Elena, Ryzhikova Kristina, Bure Irina, Golovinskii Pavel, Koporov Sergey, Bryun Evgeniy, Sychev Dmitry
Abstract excerpt
BACKGROUND: Previous studies have shown that cytochrome P450 2D6 (CYP2D6) is involved in the metabolism of fluvoxamine, the activity of which is highly dependent, inter alia, on the polymorphism of the gene encoding it. The objective of our study was to investigate the effect of 1846G>A polymorphism of the CYP2D6 gene on the efficacy and safety of fluvoxamine, using findings on CYP2D6 enzymatic activity and on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
